Literature DB >> 1945311

Effect of intravitreal dexamethasone on ocular histopathology in a rabbit model of endophthalmitis.

D P Maxwell1, B D Brent, J G Diamond, L Wu.   

Abstract

The histologic and clinical effect of intravitreal dexamethasone was studied in a rabbit model of experimentally induced gentamicin sensitive Staphylococcal epidermidis endophthalmitis. The study compared four treatment groups: vitrectomy alone (group I), vitrectomy plus intravitreal gentamicin (group II), vitrectomy plus intravitreal gentamicin and dexamethasone (group III), and intravitreal gentamicin and dexamethasone without vitrectomy (group IV). All eyes treated with dexamethasone, with or without vitrectomy, exhibited less clinical and histologic manifestations of inflammation. This study suggests that suppression of inflammation through the use of intravitreal dexamethasone leads to preservation of ocular architecture with potentially improved retinal function and visual benefit.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1945311     DOI: 10.1016/s0161-6420(91)32108-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

1.  Intraocular dexamethasone produces a harmful effect on treatment of experimental Staphylococcus aureus endophthalmitis.

Authors:  T A Meredith; H E Aguilar; C Drews; A Sawant; S Gardner; L A Wilson; H E Grossniklaus
Journal:  Trans Am Ophthalmol Soc       Date:  1996

2.  Passage of drugs through different intraocular microdialysis membranes.

Authors:  J Waga; B Ehinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-01       Impact factor: 3.117

Review 3.  Infectious endophthalmitis after cataract surgery.

Authors:  D S Hughes; R J Hill
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

Review 4.  Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis.

Authors:  G A Stern
Journal:  Trans Am Ophthalmol Soc       Date:  1993

Review 5.  Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Authors:  Michelle C Callegan; Michael Engelbert; David W Parke; Bradley D Jett; Michael S Gilmore
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial.

Authors:  Ivan M Gan; Luana C Ugahary; Jaap T van Dissel; Eric Feron; Ed Peperkamp; Marc Veckeneer; Paul G H Mulder; Gert Jan Platenkamp; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-19       Impact factor: 3.117

7.  A prospective multicenter randomized placebo-controlled trial of dexamethasone as an adjuvant in the treatment of postoperative bacterial endophthalmitis: interim safety analysis of the study drug and analysis of overall treatment results.

Authors:  Eric W Lindstedt; Carlien A Bennebroek; Dymph J van der Werf; Marc Veckeneer; Annette Ossewaarde-van Norel; Chris C Mayland Nielsen; Rene J Wubbels; Jaap T van Dissel; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-10       Impact factor: 3.117

8.  Experimental postoperative endophthalmitis.

Authors:  R K Forster
Journal:  Trans Am Ophthalmol Soc       Date:  1992

9.  Treatment of exogenous Candida endophthalmitis in rabbits with oral fluconazole.

Authors:  S S Park; D J D'Amico; B Paton; A S Baker
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

10.  Intravitreal Infliximab Injection to Treat Experimental Endophthalmitis.

Authors:  Osman Ondas; Orhan Ates; Sadullah Keles; Kenan Yildirim; Orhan Baykal; Selina Aksak Karamese; Murat Karamese; Hakan Uslu; Mustafa Yildirim; Muhammet Emin Naldan; Irem Ates
Journal:  Eurasian J Med       Date:  2017-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.